Followers | 15 |
Posts | 895 |
Boards Moderated | 0 |
Alias Born | 04/28/2018 |
Tuesday, August 29, 2023 9:40:21 AM
Recent NVCR News
- Novocure gibt positive Ergebnisse der Phase-3-Studie PANOVA-3 zur Tumor Treating Fields (TTFields)-Therapie bei Bauchspeicheldrüsenkrebs bekannt • Business Wire • 12/05/2024 06:00:00 AM
- Novocure annonce des résultats positifs de l'essai clinique de phase 3 PANOVA-3 sur les champs de traitement des tumeurs (TTFields) pour le cancer du pancréas • Business Wire • 12/05/2024 06:00:00 AM
- ノボキュア、膵がんに対する腫瘍治療電場療法(TTフィールド)の第3相臨床試験PANOVA-3のトップライン結果を発表 • Business Wire • 12/04/2024 10:00:00 PM
- Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer • Business Wire • 12/02/2024 12:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/02/2024 12:00:16 PM
- Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer • Business Wire • 12/02/2024 12:00:00 PM
- Novocure to Participate in Upcoming Investor Conferences • Business Wire • 11/27/2024 12:00:00 PM
- Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma • Business Wire • 11/21/2024 12:05:00 PM
- FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma • Business Wire • 11/21/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2024 09:27:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:34:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:34:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:32:28 PM
- ノボキュア、2024年度第3四半期の決算を発表 • Business Wire • 10/31/2024 02:36:00 PM
- Novocure présente ses résultats financiers pour le troisième trimestre 2024 • Business Wire • 10/31/2024 02:36:00 PM
- Novocure meldet Finanzergebnisse des dritten Quartals 2024 • Business Wire • 10/31/2024 02:36:00 PM
- ノボキュア、クリストフ・ブラクマン氏を最高財務責任者(CFO)に任命 • Business Wire • 10/31/2024 11:07:00 AM
- Novocure nomme Christoph Brackmann au poste de directeur financier • Business Wire • 10/31/2024 11:07:00 AM
- Novocure ernennt Christoph Brackmann zum Finanzvorstand • Business Wire • 10/31/2024 03:40:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 11:02:07 AM
- Novocure Appoints Christoph Brackmann as Chief Financial Officer • Business Wire • 10/30/2024 11:02:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/30/2024 11:00:29 AM
- Novocure Reports Third Quarter 2024 Financial Results • Business Wire • 10/30/2024 11:00:00 AM
- FDA genehmigt Optune Lua® von Novocure zur Behandlung des metastasierenden nicht-kleinzelligen Lungenkarzinoms • Business Wire • 10/22/2024 05:00:00 AM
- ノボキュアのOptune Lua®、転移性非小細胞肺がんの治療用としてFDAの承認を取得 • Business Wire • 10/20/2024 10:00:00 PM
FEATURED Actelis Networks Bags Significant Orders for Seattle and Washington D.C. New Report Shows Their Potential as Smart City Market Eyes Trillions and Infrastructure Cyber Security Gains Importance - $ASNS • Dec 11, 2024 8:30 AM
Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN • SLXN • Dec 11, 2024 9:22 AM
Actelis Networks Bags Significant Orders for Seattle and Washington D.C. New Report Shows Their Potential as Smart City Market.. • ASNS • Dec 11, 2024 8:30 AM
Consumer Automotive Finance, Inc. Cancels an Additional 50 Million Common Shares with Shareholder Commitment to Retire 250 Million More Common Shares • CAFI • Dec 10, 2024 1:30 PM
Strategic Investments Spark Renewed Interest in Multi-Club Ownership Models • MSGS • Dec 10, 2024 1:11 PM
Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance • CAFI • Dec 9, 2024 9:30 AM